Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Related Posts
Florida’s Space Coast Braces for Impact—From Elon Musk
SpaceX wants to launch the world’s largest and most powerful rocket dozens of times annually in an area that has gotten crowded with people and […]
Energy & Utilities Roundup: Market Talk
Galp, Reliance Industries and more in the latest Market Talks covering Energy and Utilities.
U.S. Steel, Nippon Steel Challenge Biden’s Decision to Kill $14.1 Billion Deal
The companies accuse the president, head of steelworkers union and Cleveland-Cliffs CEO of teaming up to block the transaction.